Company Filing History:
Years Active: 1992-1993
Title: Robin Levis: Innovator in Viral Vector Technology
Introduction
Robin Levis is an accomplished inventor based in Takoma Park, MD, USA. With two patents to his name, he has made significant contributions to the fields of virology and genetic engineering, particularly through his work on Sindbis virus vectors.
Latest Patents
Levis's latest patents include innovative methods for expressing heterologous coding sequences in host cells using infectious Sindbis virus vectors. The first patent showcases compositions that involve infectious Sindbis virus RNA molecules, which contain at least one heterologous coding sequence inserted within the structural region of the Sindbis virus genome. Additionally, novel methods are disclosed for producing infectious Sindbis virus particles that are tailored to express these coding sequences in transformed host cells.
The second patent focuses on RNA vectors that comprise Sindbis virus DI RNA with inserted heterologous RNA. These vectors are designed for cloning and expressing heterologous RNA in eukaryotic cells, as well as for packaging this RNA into viral particles during infection in the presence of a helper virus. The advancements made in these patents indicate a profound understanding of viral mechanisms and potential applications in genetic therapy.
Career Highlights
Robin Levis is affiliated with Washington University, where he continues his innovative work in virology and molecular biology. His research plays a vital role in advancing the understanding of viral vectors and their application in genetic research.
Collaborations
Throughout his career, Levis has collaborated with notable coworkers, including Henry V Huang and Sondra Schlesinger. Together, they have contributed to a collaborative research environment that fosters innovation and thorough exploration of viral vector technology.
Conclusion
With a focused career in developing Sindbis virus vectors, Robin Levis stands out as a key figure in the realm of virology and genetic engineering. His innovative patents reflect not only his expertise but also his commitment to advancing scientific knowledge and fostering new technologies in the field.